Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673360 · ClinicalTrials.gov registry record
Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices
A clinical trial, sponsored by ASTORA Women's Health.
- Terminated
- Registry status
- 401
- Enrollment target
NCT01673360: Clinical Trial study, sponsored by ASTORA Women's Health.
NCT01673360 is a clinical trial that was terminated before completion, run by ASTORA Women's Health. The registered enrollment target is 401 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01673360 was terminated before completion, sponsored by ASTORA Women's Health.
- TERMINATED
- Registry status
- 401 participants
- Enrollment target
Study Summary
To monitor post-market performance through evaluation of short and long-term performance via: * Efficacy * Safety * Patient reported outcomes
Primary Outcome
Prolapse Endpoints: • POP-Q measurement
Interventions
- DEVICE Elevate PC
- DEVICE Mini Arc Pro
- DEVICE RetroArc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2012-09 |
| Est. Completion | 2021-12 |
Why NCT01673360 stopped before completion
NCT01673360 is an observational study that tracks outcomes without assigning an intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Elevate PC is the first listed.
NCT01673360 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01673360 about?
NCT01673360 is a clinical study titled "Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices". To monitor post-market performance through evaluation of short and long-term performance via: * Efficacy * Safety * Patient reported outcomes
What is the current status of trial NCT01673360?
This trial is currently terminated. The enrollment target is 401 participants. The study started on 2012-09. Estimated completion is 2021-12.
What interventions are being tested in trial NCT01673360?
The interventions under investigation include: Elevate PC (DEVICE), Mini Arc Pro (DEVICE), RetroArc (DEVICE).
Who is sponsoring clinical trial NCT01673360?
This trial is sponsored by ASTORA Women's Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia